Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,061 | -1,193 | -8,840 | -7,496 | -6,262 |
| Depreciation Amortization | 85 | 50 | 201 | 169 | 121 |
| Accounts receivable | 33 | -40 | 1,110 | 1,323 | 147 |
| Other Working Capital | -299 | -725 | -3,888 | -3,848 | -3,716 |
| Other Operating Activity | 495 | 350 | -725 | -1,007 | 77 |
| Operating Cash Flow | $-2,746 | $-1,559 | $-12,141 | $-10,859 | $-9,633 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -3 | -5 | -5 | -3 |
| Purchase Of Investment | N/A | N/A | -299 | -299 | -299 |
| Sale Of Investment | 5,050 | 2,950 | 4,053 | 2,930 | 2,173 |
| Investing Cash Flow | $5,044 | $2,947 | $3,749 | $2,626 | $1,870 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,605 | 1,605 | 9,996 | 9,996 | 9,996 |
| End Cash Position | 3,903 | 2,993 | 1,605 | 1,764 | 2,234 |
| Net Cash Flow | $2,298 | $1,388 | $-8,391 | $-8,232 | $-7,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,746 | -1,559 | -12,141 | -10,859 | -9,633 |
| Capital Expenditure | -6 | -3 | -5 | -5 | -3 |
| Free Cash Flow | -2,752 | -1,562 | -12,145 | -10,863 | -9,636 |